Meet Phillips Medisize at MD&M Midwest
Visit Phillips Medisize at booth 3520 during MD&M Midwest 2026. Explore how integrated contract development and manufacturing organization (CDMO) services and electronic connectivity expertise can help support medical device programs from early development through scale-up and commercial launch.
Phillips Medisize brings together design and development, prototyping, design for manufacturing, advanced molding, complex assembly, cable assemblies and medical connector solutions. By considering device architecture, manufacturing and interconnect requirements earlier, medical device teams can make more informed decisions, reduce avoidable development risk and prepare for scalable production.
Connect with the team to discuss your next medical device program and learn how Phillips Medisize and Molex capabilities can contribute across the product life cycle capabilities can contribute across the product life cycle.
Coffee Talk: Make Interconnect Decisions Earlier
Wednesday, Oct. 28
10:30 to 11:15 a.m. Central time
Room 102BC
Speakers
- Ben Austin, Director of Business Development, Phillips Medisize
- Greg VanHecke, Global Product Manager, MedTech, Phillips Medisize
- Dan Ratzlaff, Global Medical Business Manager, Smiths Interconnect, a Molex company
Interconnect is often one of the last items addressed in medical device development. In this engaging panel discussion, experts in product development, engineering and commercialization will share practical lessons from supporting products through development, scale-up and commercial launch.
Through examples and case studies, the panel will explore how delayed interconnect decisions can contribute to technical challenges, manufacturing constraints, regulatory and commercial delays, scalability concerns and unexpected issues in clinical environments.
Attendees will gain practical guidance on when to engage interconnect specialists, how to reduce unnecessary development risk and why specifications, desk research and early assumptions may not fully reflect real-world use. The discussion will highlight how earlier interconnect decisions can support manufacturability, usability, clinical acceptance and commercial success.